Page last updated: 2024-08-24

1,2-distearoyllecithin and Hemophilia B

1,2-distearoyllecithin has been researched along with Hemophilia B in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chivukula, P; Karmali, PP; Limphong, P; Ramaswamy, S; Tachikawa, K; Tonnu, N; Vega, JB; Verma, IM	1

Other Studies

1 other study(ies) available for 1,2-distearoyllecithin and Hemophilia B

Article	Year
Systemic delivery of factor IX messenger RNA for protein replacement therapy. Proceedings of the National Academy of Sciences of the United States of America, 2017, 03-07, Volume: 114, Issue:10 Topics: Animals; Cholesterol; Cytokines; Disease Models, Animal; Drug Carriers; Drug Compounding; Drug Evaluation, Preclinical; Factor IX; Female; Genetic Therapy; Hemophilia B; Humans; Hydrogen-Ion Concentration; Injections, Intravenous; Liver; Male; Mice; Mice, Knockout; Nanoparticles; Phosphatidylcholines; Recombinant Proteins; RNA, Messenger	2017

Article

Year

Systemic delivery of factor IX messenger RNA for protein replacement therapy.

Proceedings of the National Academy of Sciences of the United States of America, 2017, 03-07, Volume: 114, Issue:10

Topics: Animals; Cholesterol; Cytokines; Disease Models, Animal; Drug Carriers; Drug Compounding; Drug Evaluation, Preclinical; Factor IX; Female; Genetic Therapy; Hemophilia B; Humans; Hydrogen-Ion Concentration; Injections, Intravenous; Liver; Male; Mice; Mice, Knockout; Nanoparticles; Phosphatidylcholines; Recombinant Proteins; RNA, Messenger

2017